Profile
PRPO DHR-PB TMO DHR IDXX A
Company Name Precipio, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $8.85M $916.76B $160.15B $141.09B $35.45B $30.30B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Mr. Ilan Danieli Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
PRPO DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
PRPO DHR-PB TMO DHR IDXX A
Last Close $6.03 $1261.26 $424.24 $197.14 $437.44 $106.28
High 52 $10.14 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $4.35 $1261.26 $419.59 $174.64 $361.04 $99.29
Price vs. 52 Week High -40.53 % 0 % -32.04 % -29.78 % -20.25 % -31.27 %
Price vs. 52 Week Low 38.62 % 0 % 1.11 % 12.88 % 21.16 % 7.04 %
Total Return
PRPO DHR-PB TMO DHR IDXX A
1 Month Return -9.53 % 0 % -17.41 % -6.31 % 4.72 % -11.36 %
3 Month Return -7.66 % 0 % -26.2 % -19.8 % 0.48 % -29.82 %
6 Month Return -4.59 % 0 % -23.47 % -19.66 % -3.09 % -18.37 %
9 Month Return 8.84 % 0 % -30.12 % -28.03 % -6.87 % -22.6 %
YTD Return 8.85 % 0 % -18.45 % -14.12 % 5.8 % -20.89 %
1 Year Return 0.08 % 0 % -26.04 % -20.05 % -12.39 % -22.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PRPO DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.57 % - 0.91 %
Dividend Paid and Capex Coverage Ration (TTM) 1.97 % 2.93 % 4.05 % 2.93 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Profitability
PRPO DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 40.52 % 59.74 % 41.74 % 59.74 % 61.08 % 53.97 %
Return on Assets TTM -25.24 % 4.76 % 6.58 % 4.76 % 26.96 % 10.57 %
Return on Equity TTM -35.07 % 7.47 % 13.34 % 7.47 % 55.82 % 20.95 %
Return on Capital Employed TTM -33.13 % 6.66 % 8.53 % 6.66 % 50.78 % 14.73 %
Net Income Per EBT TTM 100 % 83.59 % 92.18 % 83.59 % 80 % 84.78 %
EBT Per Ebit TTM 101.76 % 93.35 % 96.45 % 93.35 % 98.21 % 100.34 %
EBIT Per Revenue TTM -23.52 % 20.26 % 17.08 % 20.26 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM 35.04 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Receivables Turnover TTM 22.43 6.79 5.07 6.79 6.94 4.92
Payables Turnover TTM 17.25 5.57 - 5.57 13.28 5.5
Inventory Turnover TTM 14.72 3.79 4.78 3.79 3.97 3.02
Fixed Asset Turnover TTM 1098.84 % 466.14 % 459.74 % 466.14 % 470 % 359.75 %
Asset Turnover TTM 105.45 % 30.11 % 43.31 % 30.11 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM 0.3 8.72 21.53 8.72 11.29 5.95
Free Cash Flow Per Share TTM 0.15 6.84 17.79 6.84 9.7 4.94
Cash Per Share TTM 94.31 % 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM 2.45 % 26.23 % 18.97 % 26.23 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 49.2 % 78.46 % 82.61 % 78.46 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM 35.04 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Price To Free Cash Flows Ratio TTM 40.95 28.68 23.82 28.78 44.42 21.51
Price To Operating Cash Flows Ratio TTM 19.73 22.53 19.7 22.6 38.75 17.85
Price Cash Flow Ratio TTM 19.73 22.53 19.7 22.6 38.75 17.85
Income Statement (TTM)
PRPO DHR-PB TMO DHR IDXX A
Revenue $0.02B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0.01B $14.21B $18.11B $14.21B $2.38B $3.54B
Gross Profit Ratio 47.35% 59.5% 42.23% 59.5% 61.04% 54.3%
EBITDA $-0B $4.86B $11.54B $4.86B $1.27B $1.49B
Net Income $-0B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -2.93 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
PRPO DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $0B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.01B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $0.02B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
PRPO DHR-PB TMO DHR IDXX A
Net Income $-0B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $-0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $0B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
ADVB Advanced Biomed Inc. Common Stock 1.81
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.539
BIAF bioAffinity Technologies, Inc. 0.499
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
ETFs With Exposure to PRPO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
VXF Vanguard Extended Market Index Fund 0 170
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 92.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 92.07
DFAU Dimensional US Core Equity Market ETF 0 37.72
VTSAX Vanguard Total Stock Market Index Fund 0 131.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VITSX Vanguard Total Stock Market Index Fund 0 131.83
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.3
Unlock